(S (SBAR (IN While) (S (NP (NP (DT a) (JJ large) (NN body)) (PP (IN of) (NP (NN research)))) (VP (VBZ has) (ADVP (RB formally)) (VP (VBN identified) (NP (NN apolipoprotein) (NN E) (PRN (-LRB- -LRB-) (NP (NN APOE)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT a) (JJ major) (JJ genetic) (NN risk) (NN marker)) (PP (IN for) (NP (NNP Alzheimer) (NN disease))))))))) (, ,) (NP (VBG accumulating) (NN evidence)) (VP (VBZ supports) (NP (DT the) (NN notion)) (SBAR (IN that) (S (NP (JJ other) (NN risk) (NNS markers)) (VP (MD may) (VP (VB exist)))))) (. .))
(S (NP (DT The) (ADJP (NP (JJ traditional) (NNP Alzheimer)) (HYPH -) (JJ specific)) (NN signature) (NN analysis) (NNS methods)) (, ,) (ADVP (RB however)) (, ,) (VP (VBP have) (RB not) (VP (VBN been) (ADJP (JJ able) (S (VP (TO to) (VP (VB make) (NP (NP (NP (JJ full) (NN use)) (PP (IN of) (NP (JJ rich) (NML (NN protein) (NN expression)) (NNS data)))) (, ,) (RB especially) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NNS attributes))))))))))) (. .))
(S (NP (DT This) (NN paper)) (VP (VBZ develops) (NP (DT a) (JJ novel) (NN feature) (NN selection) (NN method)) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ pathogenic) (NNS factors)) (PP (IN of) (NP (NNP Alzheimer) (NN disease)))) (S (VP (VBG using) (NP (DT the) (ADJP (JJ proteomic) (CC and) (JJ clinical)) (NNS data)))))))) (. .))
(S (NP (DT This) (NN approach)) (VP (VBZ has) (VP (VBN taken) (NP (NP (DT the) (NNS weights)) (PP (IN of) (NP (NN network) (NNS nodes)))) (PP (IN as) (NP (NP (DT the) (NN importance) (NN order)) (PP (IN of) (NP (NML (NN signaling) (NN protein)) (NN expression) (NNS values))))))) (. .))
(S (PP (IN After) (S (VP (VBG generating) (CC and) (VBG evaluating) (NP (DT the) (NN candidate) (NN subset))))) (, ,) (NP (DT the) (NN method)) (VP (VBZ helps) (S (VP (TO to) (VP (VB select) (NP (NP (DT an) (JJ optimal) (NN subset)) (PP (IN of) (NP (NP (NN proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBD achieved) (NP (DT an) (NN accuracy)) (NP (NP (QP (JJR greater) (IN than) (CD 90)) (NN %)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ superior) (PP (IN to) (NP (NP (JJ traditional) (NML (NN machine) (NN learning)) (NNS methods)) (PP (IN for) (NP (JJ clinical) (NNP Alzheimer) (NN disease) (NN diagnosis)))))))))))))))))))) (. .))
(S (PP (IN Besides) (NP (S (S (VP (VBG identifying) (NP (DT a) (NML (JJ proteomic) (NN risk)) (NN marker)))) (CC and) (ADVP (RB further)) (S (VP (VB reinforce) (NP (NP (DT the) (NN link)) (PP (IN between) (NP (JJ metabolic) (NN risk) (NNS factors))))))) (CC and) (NP (NNP Alzheimer) (NN disease)))) (, ,) (NP (DT this) (NN paper)) (ADVP (RB also)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NML (NN apidonectin) (HYPH -) (VBN linked)) (NNS pathways)) (VP (VBP are) (NP (DT a) (JJ possible) (NML (JJ therapeutic) (NN drug)) (NN target)))))) (. .))
